TMC
BIOL
Trellus Management Company’s Biolase, Inc. BIOL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-16,389
| Closed | -$9K | – | 86 |
|
|
2019
Q4 | $9K | Hold |
16,389
| – | – | 0.02% | 60 |
|
|
2019
Q3 | $15K | Sell |
16,389
-100,000
| -86% | -$91.5K | 0.02% | 64 |
|
|
2019
Q2 | $171K | Hold |
116,389
| – | – | 0.23% | 57 |
|
|
2019
Q1 | $277K | Sell |
116,389
-28,524
| -20% | -$67.9K | 0.53% | 47 |
|
|
2018
Q4 | $143K | Buy |
144,913
+33,111
| +30% | +$32.7K | 0.32% | 44 |
|
|
2018
Q3 | $231K | Buy |
+111,802
| New | +$231K | 0.33% | 51 |
|
|
2018
Q2 | – | Sell |
-375,028
| Closed | -$152K | – | 75 |
|
|
2018
Q1 | $152K | Sell |
375,028
-202,326
| -35% | -$82K | 0.28% | 61 |
|
|
2017
Q4 | $246K | Buy |
577,354
+202,326
| +54% | +$86.2K | 0.34% | 54 |
|
|
2017
Q3 | $226K | Buy |
375,028
+24,171
| +7% | +$14.6K | 0.31% | 62 |
|
|
2017
Q2 | $340K | Buy |
350,857
+59,104
| +20% | +$57.3K | 0.5% | 46 |
|
|
2017
Q1 | $394K | Buy |
291,753
+215,826
| +284% | +$291K | 0.6% | 45 |
|
|
2016
Q4 | $106K | Buy |
75,927
+11,726
| +18% | +$16.4K | 0.16% | 61 |
|
|
2016
Q3 | $112K | Buy |
64,201
+3,900
| +6% | +$6.8K | 0.16% | 59 |
|
|
2016
Q2 | $71K | Hold |
60,301
| – | – | 0.12% | 53 |
|
|
2016
Q1 | $79K | Hold |
60,301
| – | – | 0.14% | 56 |
|
|
2015
Q4 | $51K | Buy |
+60,301
| New | +$51K | 0.08% | 72 |
|